RNS Number:9973G
Sagentia Group AG
05 November 2007



                               SAGENTIA GROUP AG
                                ('The Company')

                                 Trading Update



The board of Sagentia Group AG, a leading integrated technology consulting,
development and venturing organisation, today issued the following trading
update for the year ending 31 December 2007.


Year to date order intake for the Company's consulting activities to the end of
October 2007 is #15.4m, up 12% year-on-year (2006: #13.7m). The consulting
activities have returned to profitability during the second half and Directors
are confident that full year order intake for 2007 will comfortably exceed that
of 2006 (#15.9m).


The outlook for the technology development consulting market remains positive
and trading remains in line both with the Board's expectation and statements
made in the Company's Interim statement issued on 5th September 2007.



                                     -Ends-


Enquiries:


Sagentia Group AG
Martin Frost (44) 1223 875200

www.sagentiagroup.com


Hansard Group
Andrew Tan (44) 207 2451100


www.hansardgroup.co.uk


Notes to editors:



Sagentia Group AG


Sagentia Group is a leading international technology consulting and venturing
organisation, with a reputation for successfully commercialising emerging
science and technology. The Group comprises two principal operating companies,
Sagentia and Chord Capital.


Sagentia is one of the world's pre-eminent technology management and product
development companies. For 20 years the business has shown an unwavering
commitment to innovation that has led to the launch of breakthrough products.


Sagentia's facilities include state-of-the-art laboratories and are located in
Europe in Cambridge, Frankfurt, and Stockholm; in Boston and Baltimore in the
USA and in Hong Kong.


The Group's venture management activities are managed through its FSA-regulated
fund manager Chord Capital Limited. Through Chord Capital, venture and investee
companies gain access to business building and corporate finance skills. Recent
ventures and investments include CMR Fuel Cells plc and Nanoscience plc, listed
on AIM, Sphere Medical Ltd and Atraverda Ltd.


Sagentia Group is quoted on the LSE (SGA.L)






                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
TSTIIFFDLALEIID
Sagentia Grp (LSE:SGA)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more Sagentia Grp Charts.
Sagentia Grp (LSE:SGA)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more Sagentia Grp Charts.